Investigational Drug Details
| Drug ID: | D513 |
| Drug Name: | Zuretinol acetate |
| Synonyms: | |
| Type: | small molecule |
| DrugBank ID: | DB12112 |
| DrugBank Description: | Zuretinol acetate has been used in trials studying the treatment of Impaired Dark Adaptation, RP (Retinitis Pigmentosa), Retinitis Pigmentosa (RP), and LCA (Leber Congenital Amaurosis). |
| PubChem ID: | 10245972 |
| CasNo: | 29584-22-3 |
| Repositioning for NAFLD: | Yes |
| SMILES: | CC(=O)OC\C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C |
| Structure: |
|
| InChiKey: | QGNJRVVDBSJHIZ-AQDFTDIISA-N |
| Molecular Weight: | 328.4883 |
| DrugBank Targets: | |
| DrugBank MoA: | |
| DrugBank Pharmacology: | |
| DrugBank Indication: | |
| Targets: | |
| Therapeutic Category: | |
| Clinical Trial Progress: | |
| Latest Progress: |
| Trial ID | Source ID | Phases | Status | Study Results | Start Date | Last Update Posted |
|---|
| Target ID | Target Name | GENE | Action | Class | UniProtKB ID | Entry Name |
|---|
| Strategy ID | Strategy | Synonyms | Related Targets | Related Drugs |
|---|
| Article ID | PMID | Source | Title |
|---|